Underlining focus on HIV/AIDS, polio and affordable and safe medicines, the Indian government said with National Rural Health Mission it has set in motion an improved access to quality healthcare for people, especially those living in rural areas, poor, women and children.
In a pair of studies posted on Biology of Reproduction — Papers in Press, researchers report that results from studies of adolescent female sheep suggest that teenaged girls who become pregnant before reaching full growth may not be able to supply their fetuses with adequate nourishment.
US President Bush’s Emergency Plan for AIDS Relief (PEPFAR) is proving effective, according to Alec Mally, counselor to the U.S. Mission to the United Nations.
A simple method of flash-heating breast milk infected with HIV successfully inactivated the free-floating virus, according to a new study led by researchers at the Berkeley and Davis campuses of the University of California.
Endotoxin, a toxic substance made by certain types of bacteria, may reduce the risk of developing the allergic skin condition eczema or wheezing in children if they are exposed to it up to age 3, suggests a study presented at the American Thoracic Society 2007 International Conference, on Sunday, May 20.
More mums are starting to breastfeed with breastfeeding rates at their highest level in England in decades, according to the latest statistics published at the start of National Breastfeeding Awareness Week and the launch of a new TV ad campaign to encourage more women to breastfeed.
An Internet search on ‘baby feeding issues’ reveals more than a million hits, proving that new moms are actively looking for information on how to best manage their babies’ nutritional needs.
The Elizabeth Glaser Pediatric AIDS Foundation has received a five-year, $9.7-million grant from the Bill & Melinda Gates Foundation to develop and test candidate vaccines to prevent HIV infection in children.
Women who receive aspirin during pregnancy are at lower risk of pre-eclampsia a pregnancy complication, revealed by researchers from Australia and the UK.
Scientists have found evidence that the cox-2 inhibitor celecoxib, a common pain reliever used to treat arthritis, may offer a new way to reduce the risk of the most common cause of brain damage in babies born prematurely.